
Phi Hoang
Examiner (ID: 1921, Phone: (571)270-3417 , Office: P/2613 )
| Most Active Art Unit | 2613 |
| Art Unit(s) | 2678, 2619, 2628, 2613, 4178 |
| Total Applications | 1057 |
| Issued Applications | 820 |
| Pending Applications | 71 |
| Abandoned Applications | 177 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 13729265
[patent_doc_number] => 20180369100
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => COSMETIC OR DERMATOLOGICAL COMPOSITION COMPRISING A MEROCYANINE AND AN OILY PHASE COMPRISING AT LEAST ONE N-SUBSTITUTED AMIDE
[patent_app_type] => utility
[patent_app_number] => 16/072679
[patent_app_country] => US
[patent_app_date] => 2017-01-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11512
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -21
[patent_words_short_claim] => 604
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16072679
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/072679 | Cosmetic or dermatological composition comprising a merocyanine and an oily phase comprising at least one N-substituted amide | Jan 25, 2017 | Issued |
Array
(
[id] => 11820459
[patent_doc_number] => 20170209397
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-07-27
[patent_title] => 'Compositions and Methods of Use of Beta-Hydroxy-Beta-Methylbutyrate (HMB) for Modulating Autophagy and Lipophagy'
[patent_app_type] => utility
[patent_app_number] => 15/411303
[patent_app_country] => US
[patent_app_date] => 2017-01-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 6
[patent_figures_cnt] => 6
[patent_no_of_words] => 5653
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 8
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15411303
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/411303 | Compositions and methods of use of b-hydroxy-b-methylbutyrate (HMB) for modulating autophagy and lipophagy | Jan 19, 2017 | Issued |
Array
(
[id] => 16915717
[patent_doc_number] => 20210188809
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-06-24
[patent_title] => IRAK4 INHIBITING AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/071200
[patent_app_country] => US
[patent_app_date] => 2017-01-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22372
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -38
[patent_words_short_claim] => 589
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16071200
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/071200 | IRAK4 inhibiting agents | Jan 17, 2017 | Issued |
Array
(
[id] => 13870711
[patent_doc_number] => 20190031696
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => COMPOUND AND USE THEREOF AND PLATINUM COMPLEX AND LIPIDOSOME THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/072614
[patent_app_country] => US
[patent_app_date] => 2017-01-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9873
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 105
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16072614
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/072614 | Compound and use thereof and platinum complex and lipidosome thereof | Jan 12, 2017 | Issued |
Array
(
[id] => 13867307
[patent_doc_number] => 20190029994
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2019-01-31
[patent_title] => BIOPHOTONIC COMPOSITIONS FOR THE TREATMENT OF OTITIS EXTERNA
[patent_app_type] => utility
[patent_app_number] => 16/068702
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20923
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16068702
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/068702 | Biophotonic compositions for the treatment of otitis externa | Jan 10, 2017 | Issued |
Array
(
[id] => 15540709
[patent_doc_number] => 10570119
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-02-25
[patent_title] => Inhibiting ataxia telangiectasia and Rad3-related protein (ATR)
[patent_app_type] => utility
[patent_app_number] => 16/069092
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 86
[patent_figures_cnt] => 98
[patent_no_of_words] => 14955
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 5
[patent_words_short_claim] => 15
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069092
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069092 | Inhibiting ataxia telangiectasia and Rad3-related protein (ATR) | Jan 10, 2017 | Issued |
Array
(
[id] => 15393775
[patent_doc_number] => 10537524
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-21
[patent_title] => Apixaban solid composition and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 16/069200
[patent_app_country] => US
[patent_app_date] => 2017-01-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11140
[patent_no_of_claims] => 24
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 37
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16069200
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/069200 | Apixaban solid composition and preparation method thereof | Jan 10, 2017 | Issued |
Array
(
[id] => 11893986
[patent_doc_number] => 09763904
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2017-09-19
[patent_title] => 'Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds'
[patent_app_type] => utility
[patent_app_number] => 15/402343
[patent_app_country] => US
[patent_app_date] => 2017-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6732
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15402343
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/402343 | Position-specific asymmetric deuterium enriched catecholamine derivatives and medicaments comprising said compounds | Jan 9, 2017 | Issued |
Array
(
[id] => 13970277
[patent_doc_number] => 10214479
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-02-26
[patent_title] => Synthesis of and compositions containing diaminoacetals and diaminoketals
[patent_app_type] => utility
[patent_app_number] => 15/397521
[patent_app_country] => US
[patent_app_date] => 2017-01-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 3
[patent_figures_cnt] => 4
[patent_no_of_words] => 29614
[patent_no_of_claims] => 54
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 65
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15397521
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/397521 | Synthesis of and compositions containing diaminoacetals and diaminoketals | Jan 2, 2017 | Issued |
Array
(
[id] => 15338963
[patent_doc_number] => 10525138
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Compound as cationic lipid
[patent_app_type] => utility
[patent_app_number] => 16/065222
[patent_app_country] => US
[patent_app_date] => 2016-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 18136
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 268
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065222
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/065222 | Compound as cationic lipid | Dec 25, 2016 | Issued |
Array
(
[id] => 13729903
[patent_doc_number] => 20180369419
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-27
[patent_title] => COMPOUNDS AND COMPOSITIONS FOR INTRACELLULAR DELIVERY OF AGENTS
[patent_app_type] => utility
[patent_app_number] => 16/065067
[patent_app_country] => US
[patent_app_date] => 2016-12-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 90485
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16065067
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/065067 | Compounds and compositions for intracellular delivery of agents | Dec 21, 2016 | Issued |
Array
(
[id] => 11704452
[patent_doc_number] => 20170172951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'NOVEL PHARMACEUTICAL COMPOSITIONS OF BENZENESULFONAMIDE DERIVATIVES FOR TREATMENT OF ADENOID CYSTIC CARCINOMA'
[patent_app_type] => utility
[patent_app_number] => 15/387221
[patent_app_country] => US
[patent_app_date] => 2016-12-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8118
[patent_no_of_claims] => 19
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15387221
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/387221 | Pharmaceutical compositions of benzenesulfonamide derivatives for treatment of adenoid cystic carcinoma | Dec 20, 2016 | Issued |
Array
(
[id] => 11704466
[patent_doc_number] => 20170172965
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-06-22
[patent_title] => 'COMPOSITIONS COMPRISING 15-HEPE AND METHODS OF USING THE SAME'
[patent_app_type] => utility
[patent_app_number] => 15/383889
[patent_app_country] => US
[patent_app_date] => 2016-12-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 5
[patent_figures_cnt] => 5
[patent_no_of_words] => 8039
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15383889
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/383889 | Compositions comprising 15-HEPE and methods of using the same | Dec 18, 2016 | Issued |
Array
(
[id] => 16518898
[patent_doc_number] => 10870102
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-12-22
[patent_title] => Radical generating catalyst, method for producing radical, method for producing oxidation reaction product, drug, and drug for agriculture and livestock
[patent_app_type] => utility
[patent_app_number] => 16/062499
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 13
[patent_figures_cnt] => 24
[patent_no_of_words] => 40164
[patent_no_of_claims] => 6
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 160
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16062499
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/062499 | Radical generating catalyst, method for producing radical, method for producing oxidation reaction product, drug, and drug for agriculture and livestock | Dec 15, 2016 | Issued |
Array
(
[id] => 12999845
[patent_doc_number] => 10023579
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2018-07-17
[patent_title] => Pyrrolopyrimidine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereof
[patent_app_type] => utility
[patent_app_number] => 15/382213
[patent_app_country] => US
[patent_app_date] => 2016-12-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 55914
[patent_no_of_claims] => 30
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 51
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15382213
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/382213 | Pyrrolopyrimidine compounds, use as inhibitors of the kinase LRRK2, and methods for preparation thereof | Dec 15, 2016 | Issued |
Array
(
[id] => 11541652
[patent_doc_number] => 20170095478
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2017-04-06
[patent_title] => 'COMBINATION THERAPY TO ENHANCE THE ANTICANCER EFFICACY OF PLATINUM DRUGS'
[patent_app_type] => utility
[patent_app_number] => 15/380776
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 9936
[patent_no_of_claims] => 35
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 15380776
[rel_patent_id] =>[rel_patent_doc_number] =>) 15/380776 | Combination therapy to enhance the anticancer efficacy of platinum drugs | Dec 14, 2016 | Issued |
Array
(
[id] => 16058221
[patent_doc_number] => 10688032
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-06-23
[patent_title] => Emulsions having UV sunscreen factors and carnosines
[patent_app_type] => utility
[patent_app_number] => 16/061861
[patent_app_country] => US
[patent_app_date] => 2016-12-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11479
[patent_no_of_claims] => 14
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 33
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061861
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061861 | Emulsions having UV sunscreen factors and carnosines | Dec 14, 2016 | Issued |
Array
(
[id] => 15338691
[patent_doc_number] => 10524999
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2020-01-07
[patent_title] => Composition comprising a combination of particular alkoxysilanes and a fatty substance
[patent_app_type] => utility
[patent_app_number] => 16/061800
[patent_app_country] => US
[patent_app_date] => 2016-12-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 4
[patent_no_of_words] => 11886
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 238
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16061800
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/061800 | Composition comprising a combination of particular alkoxysilanes and a fatty substance | Dec 13, 2016 | Issued |
Array
(
[id] => 15006065
[patent_doc_number] => 10449137
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2019-10-22
[patent_title] => Antimicrobial composition
[patent_app_type] => utility
[patent_app_number] => 16/060481
[patent_app_country] => US
[patent_app_date] => 2016-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7138
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 21
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060481
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060481 | Antimicrobial composition | Dec 11, 2016 | Issued |
Array
(
[id] => 13618341
[patent_doc_number] => 20180360722
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2018-12-20
[patent_title] => NOVEL USE
[patent_app_type] => utility
[patent_app_number] => 16/060571
[patent_app_country] => US
[patent_app_date] => 2016-12-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 132
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16060571
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/060571 | Use of proline containing dipeptides | Dec 8, 2016 | Issued |